Literature DB >> 8182368

Expression of 17 beta-hydroxysteroid dehydrogenase in the rat ovary during follicular development and luteinization induced with pregnant mare serum gonadotrophin and human chorionic gonadotrophin.

S A Ghersevich1, M H Poutanen, H J Rajaniemi, R K Vihko.   

Abstract

Antibodies against human placental 17 beta-hydroxysteroid dehydrogenase (17-HSD) and 17-HSD cDNA were used to study the expression of the corresponding enzyme in the immature rat ovary during follicular development and luteinization, which were induced by treating the animals with pregnant mare serum gonadotrophin (PMSG) or with PMSG followed by human chorionic gonadotrophin (hCG). Immuno-blot analysis indicated that the M(r) of the 17-HSD expressed in rat granulosa cells was 35,000, as previously shown for the human placental enzyme. In immunohistochemical studies of untreated immature rat ovaries, only the granulosa cells from small antral follicles were stained. One day after PMSG treatment, strong expression of 17-HSD was observed in the granulosa cells of growing Graafian follicles. A marked decrease in enzyme expression was observed in preovulatory follicles on day 2 of PMSG treatment, starting from the basal layers of granulosa cells and progressing toward the luminal cells. No 17-HSD expression was detected in luteinized follicles or corpora lutea 22 h after hCG injection. The stroma and theca cells were negative for 17-HSD staining. In Northern hybridization analyses, two 17-HSD mRNAs were detected (1.4 and 1.7 kb). The strongest expression for both mRNAs was detected after 1 day of PMSG treatment, coinciding with maximal immunostaining of the enzyme protein. Down-regulation of 17-HSD observed by immunohistochemistry was reflected in a similar decrease in mRNA expression and the signals were almost undetectable 22 h after hCG injection. Our data suggest that 17-HSD expression in rat granulosa cells is up-regulated during follicular development and, thereafter, the enzyme expression is down-regulated during luteinization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182368     DOI: 10.1677/joe.0.1400409

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Effect of quinine-loaded polysorbate-coated nanocapsules on male and female reproductive systems of rats.

Authors:  Aryele Pinto Izaguirry; Natasha Frasson Pavin; Melina Bucco Soares; Cristiano Chiapinotto Spiazzi; Flávio Arci Araújo; Luana Roberta Michels; Fábio Gallas Leivas; Daniela Dos Santos Brum; Sandra Elisa Haas; Francielli Weber Santos
Journal:  Toxicol Res (Camb)       Date:  2016-09-05       Impact factor: 3.524

2.  Prolonged stimulation by follicle-stimulating hormone is required for the induction of ovarian follicular cysts by human chorionic gonadotropin in hypophysectomized rats.

Authors:  K Bogovich
Journal:  Endocrine       Date:  1996-04       Impact factor: 3.633

3.  Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene.

Authors:  Pia Rantakari; Leena Strauss; Riku Kiviranta; Heidi Lagerbohm; Jenni Paviala; Irma Holopainen; Seppo Vainio; Pirjo Pakarinen; Matti Poutanen
Journal:  Mol Endocrinol       Date:  2007-11-29

4.  Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression.

Authors:  M M Miettinen; M V Mustonen; M H Poutanen; V V Isomaa; R K Vihko
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

5.  Conversion of Estrone to 17β-Estradiol: A Potential Confounding Factor in Assessing Risks of Environmental Estrogens to Fish.

Authors:  Mark A Tapper; Richard C Kolanczyk; Carlie A LaLone; Jeffrey S Denny; Gerald T Ankley
Journal:  Environ Toxicol Chem       Date:  2020-09-01       Impact factor: 4.218

6.  Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway in vitro.

Authors:  Xuzi Cai; Huijiao Fu; Yan Wang; Qiwen Liu; Xuefeng Wang
Journal:  J Ovarian Res       Date:  2020-11-21       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.